Skip to content

Effects of Laser Therapy on Muscle Function in COPD Patients

Effects of Light-emitting Diodes (LED) on Peripheral Muscle Function, Exercise Tolerance and Cardiorespiratory Response During Exercise in Patients With Chronic Obstructive Pulmonary Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01448564
Acronym
LTCOPD
Enrollment
27
Registered
2011-10-07
Start date
2012-06-30
Completion date
2013-12-31
Last updated
2013-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Fatigue

Keywords

Chronic Obstructive Pulmonary Disease, Fatigue, laser therapy

Brief summary

Light-emitting diodes (LEDs) have been used to minimize muscle fatigue in athletes and healthy subjects. Patients with chronic obstructive pulmonary disease (COPD) are susceptible to early muscle fatigue. The objective of this study is to assess the acute effects of LEDs on muscle function, exercise capacity, and cardiorespiratory responses during isometric and dynamic exercise in patients with COPD. This study will assess 30 patients with moderate to severe obstruction (FEV1 ≤ 70% predicted). Isometric and dynamic protocols will be conducted in two visits each, for a total of four visits a week a part. First, a venous blood sample will be taken from the patients. The isometric protocol will start with the determination of the maximum voluntary isometric contraction (MIVC) to determine the workload (60% of MIVC) for the isometric endurance test (IET). Patients will be randomized to receive either the placebo or LED application. Immediately after finishing this procedure, the patients will carry out the IET until the limit of tolerance or until a 20% fall of strength is observed. After the test, another blood sample will be taken. In the other visit (one week later), the same order of procedures will be performed, except with the opposite (LED or placebo). For the dynamic protocol, the same procedures described above will be followed except with the maximal incremental cycle ergometer test used instead of the IET. The electromyography will be recorded during the isometric and dynamic protocols. Differences in muscle function, exercise capacity, and cardiorespiratory responses between the LED and placebo applications will be analyzed. The therapeutic effects of LED could minimize muscle fatigue in patients with COPD by increasing exercise tolerance.

Interventions

OTHERLaser therapy

The therapeutic effects of low intensity lasers are: (i) analgesic and anti-inflammatory, (ii) regeneration, (iii) tissue healing and (vi) recovery from muscle fatigue.

The application of laser therapy will be a low intensity laser.

Sponsors

Eduardo Foschini Miranda
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* 35 patients will be selected (see sample calculation in Section 6) who have moderate to severe obstruction (FEV1 ≤ 70% predicted) and stable disease, as suggested by the absence of changes in medication in the last 4 weeks.

Exclusion criteria

* Ischemic heart disease, recent surgery, neuro-muscular or orthopedic that limit the performance of the protocol. * Patients will only be included in the study after signing the consent form.

Design outcomes

Primary

MeasureTime frame
Analysis of the recovery time for the isometric and dynamic protocolMeasures muscular endurance will be compared after a period of 1 week.

Secondary

MeasureTime frame
Analysis of lactate levels and the activity of CK and C-reactive protein (CRP).Measures blood will be compared after a period of 1 week.

Countries

Brazil

Contacts

Primary ContactEduardo Miranda
foschinimedu@ig.com.br05511 36659748
Backup ContactSimone Dal Corso
simonedc@uninove.br05511 36659748

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026